Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 8 Oct, 01:30 am
Five Notable Stock Gainers on October 6, 2026 Five securities gained between 20.9% and 52.7% , accompanied by elevated trading volume in several names. Acquisition news, blockchain contracts, AI initiatives and federal financing contributed to some of the gains. The gainers repre
Evercore ISI raised its price target for Marvell Technology, Inc. to $433.00 from $275.00 , maintaining an Outperform rating. Marvell projects significant revenue growth, targeting $20.00 billion by fiscal 2028 and $70.00 billion – $90.00 billion by fiscal 2031, driven by AI infr
Neogen (NASDAQ: NEOG) reported strong financial results, surpassing analyst expectations for both earnings per share and revenue . The company announced a strategic equity investment and collaboration with Hinalea Imaging Corp. to advance digital food safety tools . Despite the p
PepsiCo (NASDAQ: PEP) is set to report Q3 2026 earnings, with analysts expecting $2.29 EPS and $25.00 billion in revenue. The company faces challenges in North American sales, with organic revenue declining, prompting adjustments in package sizes and pricing, and adapting to chan
Stryker (NYSE: SYK) faces a reduced price target from Truist Financial due to ongoing manufacturing issues, despite its strong market position in medical devices . A significant stock drop on September 8, 2026, wiped out over $10 billion from its market value , highlighting inves
Citigroup (NYSE: C) maintains a "Sell" rating on Bank OZK (NASDAQ: OZK) , with the stock trading at $45.59 . Bank OZK is set to release its third-quarter 2026 earnings after market close on October 20. The latest balance sheet reveals $41.70 billion in total assets and $6.28 bill
Pfizer Price Target Increase: Scotiabank (NYSE: BNS) has raised its price target for Pfizer (NYSE: PFE) to $33.00 , indicating a potential upside of 20.9% from its current trading price. Analyst Sentiment: Pfizer holds a strong Zacks Rank of #2 (Buy) , suggesting an improving ear
Citigroup (NYSE: C) has increased its price target for AstraZeneca (NYSE: AZN) , maintaining a Buy rating, following promising clinical trial developments. The revised target reflects significantly higher peak annual sales forecasts for key drugs like tozorakimab and SERENA-6, ou
An analyst set a $67 price target for Devon Energy (NYSE:DVN) , suggesting significant upside potential for the oil and natural gas producer . Devon Energy has consistently beaten earnings estimates in recent quarters, showcasing strong financial performance. The company faces st
Analyst Ivan Feinseth of Tigress Financial has raised the price target for Amazon (NASDAQ: AMZN) stock to $385.00 from $315.00 , indicating a potential 50.80% upside. Amazon Web Services (AWS) is experiencing high demand, with 2027 capacity reserved and potential for increased pr
Analyst Bob Huang from Morgan Stanley (NYSE:MS) adjusted American International Group (NYSE:AIG) 's price target to $80.00 , noting the stock was trading below this new target. Investors are keenly awaiting American International Group's Q3 2026 earnings report and conference cal
Vertiv Holdings (NYSE: VRT) receives conflicting analyst ratings: a "Sell" from GLJ Research and an "Outperform" from BMO Capital. Despite a recent stock pullback , strong operating cash flow , driven by customer prepayments for data center equipment , suggests potential underval
Apogee Enterprises (NASDAQ: APOG) exceeded fiscal Q2 adjusted earnings estimates, reporting $1.17 per share against an estimated $0.59 . The company also surpassed revenue expectations, reaching $391.14 million compared to the $362.6 million estimate. Apogee provided optimistic f
McKesson (NYSE: MCK) received a price target of $977.00 from Morgan Stanley, indicating a 6.70% upside from its current share price of $915.45 . McKesson has agreed to acquire Option Care Health (NASDAQ: OCAH) for $32.05 per share, valuing the deal at approximately $5.80 billion
Ameriprise Financial (NYSE: AMP) , a leading provider of financial advice and investment management , currently holds a Market Perform rating from BMO Capital, with shares trading at $494.94 . The stock is highlighted by Zacks Investment Research as a potential opportunity for va
RPM International (NYSE: RPM) reported first-quarter earnings per share of $1.98 , surpassing the $1.95 estimate. Despite the earnings beat , RPM shares experienced a 4.1% decline, opening at $95.17 , close to their 52-week low of $92.92 . The company achieved a robust net margin
Mizuho Securities raises Accenture's (NYSE: ACN) price target to $241 , indicating potential upside for the consulting and technology services firm. Despite strong fiscal Q4 revenue growth of 7% , Accenture's fiscal 2027 organic growth outlook is modest, ranging from 1%–3.5% . Fu
Analyst Upgrade: B. Riley upgraded Skyworks Solutions to Buy, citing the company’s strategic position following the merger. Strategic Acquisition: The merger with Qorvo expands Skyworks’ product portfolio in key semiconductor areas, including radio-frequency and mixed
Headlines provided by Investing.com